One of this week's major news items in the world of pharma is the less-than-enthusiastic response of an FDA panel to Boehringer-Ingelheim's experimental "sexual desire for women" pill, flibanserin. I …
Impactiviti Daily 061710 Top Pharma News
***** TODAY’S NEWS: Boehringer's female sex pill: maybe not. The drug “failed to demonstrate a statistically significant improvement” in sexual desire, Food and Drug Administration staff said in a …
Continue Reading about Impactiviti Daily 061710 Top Pharma News →
Impactiviti Daily 051910 Top Pharma News
***** TODAY’S NEWS Sometimes I can't help but voice a bit of skepticism, especially when it comes to sexual disorder treatments. So, count me as less than convinced about this experimental treatment …
Continue Reading about Impactiviti Daily 051910 Top Pharma News →
Impactiviti Daily 032310
***** TODAY’S NEWS Boehringer's Mirapex ER for once-daily Parkinson's treatment is approved by FDA. When the FDA surprisingly approves a previously-rejected drug. Don't do this. Can you tell …
Impactiviti Daily 022210
TODAY’S NEWS Big news for Novartis on two fronts - Novartis has received a couple of pieces of good news from regulators in the USA this morning who have approved its meningococcal vaccine Menveo …
Impactiviti Daily 121809
This will be the final Impactiviti Daily for 2009. We'll pick up again in the new year. Have a delightful holiday season! TODAY’S NEWS Deals - J&J and Merck get hits, Biogen strikes out. From …